Long-term outcomes of pulmonary thromboendarterectomy: predictors of residual pulmonary hypertension

Kurbanova DB, Mershin KV, Danilov NM, et al. Long-term outcomes of pulmonary thromboendarterectomy: predictors of residual pulmonary hypertension. Russian Cardiology Bulletin. 2025;20(4):72‑79. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20252004172

Подписка 2026 Кардиологический вестник (Russian Cardiology Bulletin)

Использование инфографики авторами научных работ

Close metadata

INTRODUCTION

Pulmonary thromboendarterectomy (TEE) is the gold standard of treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). Residual pulmonary hypertension (PH) may worsen prognosis of disease after TEE, and incidence reaches 40%. Identification of risk factors of residual PH in long-term period after surgery is an actual issue.

MATERIAL AND METHODS

A retrospective observational study included 58 patients with CTEPH who underwent TEE in 2016—2020. We studied long-term results and obtained data in 96.6% patients (n=56); median follow-up was 66 (57—78) months. The primary endpoint was residual PH as mPAP ≥25 mmHg according to right heart catheterization (RHC) or sPAP ≥40 mmHg according to echocardiography. Statistical analysis was performed. Sensitivity and specificity of predictors of residual PH were analyzed using ROC analysis (cut-off value was established using Youden index).

RESULTS

The 5-year cumulative survival rate was 94.6%. Recurrence of pulmonary embolism was diagnosed in 1 patient (1.7%). Among survivors, residual PH was diagnosed in 12 (22.6%) patients. Patients in this group were older (61.2±8.7 vs. 49.8±13.2 years, p=0.007) and had higher PVR on the first day after TEE (361.8±130.3 vs. 250.7±82.2 dynes/sec/cm^-5, p<0.001) with a cut-off PVR 321 dyne/sec/cm-5 (sensitivity 75.0%, specificity 80.5%). Patients with residual PH were treated with balloon angioplasty of pulmonary arteries (n=4, 33.3%) and PAH-specific therapy (n=10, 83.3%).

CONCLUSION

The incidence of residual PH after successful TEE within 5 years was 22.6%. Predictors of residual PH were older age and high PVR in early postoperative period. PVR>321 dynes/sec/cm^-⁵ on the 1^st day after surgery is associated with high risk of residual PH.

Keywords:

chronic thromboembolic pulmonary hypertension

pulmonary thromboendarterectomy

residual pulmonary hypertension

Authors:

Kurbanova D.B.

Chazov National Medical Research Center of Cardiology

ORCID: 0009-0005-9828-608X

Mershin K.V.

Chazov National Medical Research Center of Cardiology

ORCID: 0000-0002-7256-0563

Danilov N.M.

Chazov National Medical Research Center of Cardiology

ORCID: 0000-0001-9853-9087

Gazizov V.V.

Chazov National Medical Research Center of Cardiology

Tabakyan E.A.

Chazov National Medical Research Centre of Cardiology

ORCID: 0000-0002-9400-6651

Boykov N.V.

Chazov National Medical Research Center of Cardiology

ORCID: 0009-0007-5689-8082

Kurbanov S.K.

Chazov National Medical Research Center of Cardiology

Shiryaev A.A.

Chazov National Medical Research Centre of Cardiology

ORCID: 0000-0002-3325-9743

Received:

21.02.2025

Accepted:

17.04.2025

Close metadata

References:

Chazova IE, Martynyuk TV, Valieva ZS, Azizov VA, Akchurin RS, Ansheles AA, Vasiltseva OYa, Veselova TN, Galyavich AS, Gorbachevsky SV, Danilov NM, Edemskiy AG, Zelveyan PA, Lazareva IV, Matchin YuG, Mershin KV, Mukarov MA, Nakonechnikov SN, Saidova MA, Sarybaev ASh, Sergienko VB, Stukalova OV, Filippov EV, Chernyavsky AM, Chernyavsky MA, Shalaev SV, Shmalts AA. Eurasian association of cardiology (eac) guidelines for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension (2020). Eurasian heart journal. 2021;(1):6-43. (In Russ.). https://doi.org/10.38109/2225-1685-2021-1-6-43
Valieva ZS, Martynyuk TV. Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(7):791-796. https://doi.org/10.26442/00403660.2022.07.201741
Brookes JDL, Li C, Chung STW, et al. Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review. Annals of Cardiothoracic Surgery. 2022;11(2):68-81. https://doi.org/10.21037/acs-2021-pte-25
Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry. Journal of Thoracic and Cardiovascular Surgery. 2011;141(3):702-710. https://doi.org/10.1016/j.jtcvs.2010.11.024
Jenkins D, Madani M, Fadel E, et al. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. European Respiratory Review. 2017;26(143):160111. https://doi.org/10.1183/16000617.0111-2016
Lankeit M, Krieg V, Hobohm L, et al. Pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Journal of Heart and Lung Transplantation. 2018;37(2):250-258. https://doi.org/10.1016/j.healun.2017.06.011
Gazizov VV, Mershin KV, Tabak’yan EA, et al. Results of pulmonary thromboendarterectomy depending on different levels of pulmonary vascular resistance and angiographic index of the pulmonary artery lesion. Systemic Hypertension. 2020; 17 (1):62-68. https://doi.org/10.26442/2075082X.2020.1.200040
Gorbachevsky SV, Rakhmonov KKh, Aybazov RA, Petrosyan KV, Bockeria LA. Results of pulmonary tromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. The Bulletin of Bakoulev Center. Cardiovascular Diseases. 2024; 25 (1):56-69 (in Russ.). https://doi.org/10.24022/1810-0694-2024-25-1-56-69
Dardi F, Manes A, Guarino D, et al. Long-term outcomes after pulmonary endarterectomy. Annals of Cardiothoracic Surgery. 2022;11(2):172-174. https://doi.org/10.1016/j.athoracsur.2020.06.122
Klinkova AS, Kamenskaya OV, Loginova IYu, Chernyavsky AM, Edemsky AG, Khabarov DV, Lomivorotov VV. Results of a three-year follow-up and quality of life dynamics after pulmonary thromboendarterectomy. Russian Journal of Cardiology. 2020;25(8):3648. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3648
Avdeev SN, Barbarash OL, Valieva ZS, Volkov AV, Veselova TN, Galyavich AS, Goncharova NS, Gorbachevsky SV, Gramovich VV, Danilov NM, Klimenko AA, Martynyuk TV, Moiseeva OM, Ryzhkova DV, Simakova MA, Sinitsyn VE, Stukalova OV, Chazova I E, Chernogrivov IE, Shmalts AA, Tsareva NA. 2024 Clinical practice guidelines for Pulmonary hypertension, including chronic thromboembolic pulmonary hypertension. Russian Journal of Cardiology. 2024;29(11):6161. https://doi.org/10.15829/1560-4071-2024-6161
Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): Results from an international prospective registry. Circulation. 2011;124(18):1973-1981. https://doi.org/10.1161/CIRCULATIONAHA.110.015008
Perrot M. de, Gopalan D, Jenkins D, et al. Evaluation and management of patients with chronic thromboembolic pulmonary hypertension — consensus statement from the ISHLT. Journal of Heart and Lung Transplantation. 2021;40(11):1301-1326. https://doi.org/10.1016/j.healun.2021.07.020
López Gude MJ, Pérez de la Sota E, Forteza Gil A, et al. Pulmonary Thromboendarterectomy in 106 Patients With Chronic Thromboembolic Pulmonary Hypertension. Archivos de Bronconeumologia. 2015;51(10):502-508. https://doi.org/10.1016/j.arbres.2014.11.012
Madani MM, Auger WR, Pretorius V, et al. Pulmonary endarterectomy: Recent changes in a single institution’s experience of more than 2,700 patients. Annals of Thoracic Surgery. 2012;94(1):97-103. https://doi.org/10.1016/j.athoracsur.2012.04.004
Miwa H, Tanabe N, Jujo T, et al. Long-term outcome of chronic thromboembolic pulmonary hypertension at a single japanese pulmonary endarterectomy center. Circulation Journal. 2018;82(5):1428-1436. https://doi.org/10.1253/circj.CJ-17-1242
akurai Y, Takami Y, Amano K, et al. Predictors of Outcomes After Surgery for Chronic Thromboembolic Pulmonary Hypertension. Annals of Thoracic Surgery. 2019;108(4):1154-1161. https://doi.org/10.1016/j.athoracsur.2019.03.100
Schölzel B, Snijder R, Morshuis W, et al. Clinical worsening after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension. Netherlands Heart Journal. 2011;19(12):498-503. https://doi.org/10.1007/s12471-011-0203-4
Freed DH, Thomson BM, Tsui SSL, et al. Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy. European Journal of Cardio-thoracic Surgery. 2008;34(3):525-530. https://doi.org/10.1016/j.ejcts.2008.04.018
Hsieh WC, Jansa P, Huang WC, et al. Residual pulmonary hypertension after pulmonary endarterectomy: A meta-analysis. Journal of Thoracic and Cardiovascular Surgery. 2018;156(3):1275-1287. https://doi.org/10.1016/j.jtcvs.2018.04.110
Ivanov SN, Chernyavsky AM, Edemsky AG, Vasiltseva OYa. Chronic Thromboembolic Pulmonary Hypertension Drug Treatment. Kardiologiia. 2024;64(12):77-85. https://doi.org/10.18087/cardio.2024.12.n2784
Skoro-Sajer N, Marta G, Gerges C, et al. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax. 2014;69(2):116-122. https://doi.org/10.1136/thoraxjnl-2013-203746
Jamieson SW, Kapelanski DP, Sakakibara N, et al. Pulmonary Endarterectomy: Experience and Lessons Learned in 1,500 Cases. Annals of Thoracic Surgery. 2003;76(5):1457-1464. https://doi.org/10.1016/S0003-4975(03)00828-2
Cannon JE, Su L, Kiely DG, et al. Dynamic risk stratification of patient long-term outcome after pulmonary Endarterectomy: Results from the United Kingdom national cohort. Circulation. 2016;133(18):1761-1771. https://doi.org/10.1161/CIRCULATIONAHA.115.019470
Kallonen J, Korsholm K, Bredin F, et al. Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Pulmonary Circulation. 2022;12(2). https://doi.org/10.1002/pul2.12093